These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Serum osteocalcin and bone turnover in hyperthyroidism]. León Sanz M; Hawkins F; Larrodera L; Sarabia F; Schuller A Rev Clin Esp; 1990 Mar; 186(4):155-8. PubMed ID: 2367716 [TBL] [Abstract][Full Text] [Related]
5. Change of visfatin, C-reactive protein concentrations, and insulin sensitivity in patients with hyperthyroidism. Chu CH; Lee JK; Wang MC; Lu CC; Sun CC; Chuang MJ; Lam HC Metabolism; 2008 Oct; 57(10):1380-3. PubMed ID: 18803942 [TBL] [Abstract][Full Text] [Related]
6. Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications. Bayer MF; Kriss JP; McDougall IR J Nucl Med; 1985 Nov; 26(11):1248-56. PubMed ID: 3840528 [TBL] [Abstract][Full Text] [Related]
7. [Increased serum PIVKA-II levels in hyperthyroidism]. Morimoto M; Takeda K; Ohara E; Nishimori Y; Hisahara T; Nishida M; Sugiura T Rinsho Byori; 2001 Nov; 49(11):1146-50. PubMed ID: 11769563 [TBL] [Abstract][Full Text] [Related]
8. Serum concentrations of osteocalcin in patients with hyperthyroidism, hypothyroidism and subacute thyroiditis. Kojima N; Sakata S; Nakamura S; Nagai K; Takuno H; Ogawa T; Matsui I; Sarui H; Miura K J Endocrinol Invest; 1992; 15(7):491-6. PubMed ID: 1447487 [TBL] [Abstract][Full Text] [Related]
9. [Study of serum thrombomodulin(TM) levels in patients with hyper- or hypo- thyroidism]. Soma M; Maeda Y; Matsuura R; Sasaki I; Kasakura S; Saeki Y; Ikekubo K; Ishihara T; Kurahachi H; Sasaki S; Tagami T; Nakao K Rinsho Byori; 1997 Jan; 45(1):77-81. PubMed ID: 9022347 [TBL] [Abstract][Full Text] [Related]
10. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease. De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104 [TBL] [Abstract][Full Text] [Related]
11. Treatment of Graves' disease: effects of the administration of L-thyroxine associated with methimazole as a single daily dose. Perozim LM; Lima N; Knobel M; Cavaliere H; Medeiros-Neto G Eur J Med; 1993 Feb; 2(2):70-4. PubMed ID: 8258020 [TBL] [Abstract][Full Text] [Related]
12. Erythrocyte carbonic anhydrase-I concentrations in patients with Graves' disease and subacute thyroiditis reflect integrated thyroid hormone levels over the previous few months. Kiso Y; Yoshida K; Kaise K; Kaise N; Fukazawa H; Mori K; Abe K; Yoshinaga K J Clin Endocrinol Metab; 1991 Feb; 72(2):515-8. PubMed ID: 1899425 [TBL] [Abstract][Full Text] [Related]
14. Hyperthyroidism is associated with higher plasma endothelin-1 concentrations. Chu CH; Lee JK; Keng HM; Chuang MJ; Lu CC; Wang MC; Sun CC; Wei MC; Lam HC Exp Biol Med (Maywood); 2006 Jun; 231(6):1040-3. PubMed ID: 16741045 [TBL] [Abstract][Full Text] [Related]
15. Serum leptin and ghrelin levels in premenopausal women with stable body mass index during treatment of thyroid dysfunction. Braclik M; Marcisz C; Giebel S; Orzeł A Thyroid; 2008 May; 18(5):545-50. PubMed ID: 18466078 [TBL] [Abstract][Full Text] [Related]
19. [Study of bone involvement in hypothyroidism determining the blood levels of osteocalcin]. León Sanz M; Hawkins F; Larrodera L; Schuller A Rev Clin Esp; 1989 Nov; 185(7):345-7. PubMed ID: 2623248 [TBL] [Abstract][Full Text] [Related]
20. Osteocalcin levels in patients with hyper- and hypothyroidism. Martinez ME; Herranz L; de Pedro C; Pallardo LF Horm Metab Res; 1986 Mar; 18(3):212-4. PubMed ID: 3486152 [No Abstract] [Full Text] [Related] [Next] [New Search]